Please login to the form below

Not currently logged in
Email:
Password:

NHS news in brief

Our weekly round-up of NHS and healthcare stories
iSoft shares down
Shares in NHS software provider, iSoft, fell to an all-time low after mounting doubts that its main product, which is the mainstay of the £6.2bn overhaul of NHS IT systems, will be rolled out in time. The Lorenzo software, which is being built in Chennai, India, is though to account for the majority of the goodwill valuation in iSoft's accounts. Shares in iSoft have lost 90 per cent of their value this year. The company has also been hit by an accounting investigation after its audit firm, Deloitte, found irregularities in accounts for 2004 and 2005, leading iSoft to announce radical accounting changes.

Investigation into privately-run NHS treatment centre
A doctor who resigned from his post as lead GP at a privately-run NHS walk-in centre has written to the government to voice his concerns over safety. Speaking to Doctor magazine, Dr Anila Reddy, said nurses were being encouraged to work beyond their remits to drive down waiting lists. Atos Origin, the firm which runs the centre in Canary Wharf, London, has launched an investigation. "Patient safety is of the utmost importance and any claim regarding patient care and safety is taken extremely seriously," said a spokesman for Atos Origin. "As a result of these claims, we have now started an investigation into these alleged incidents."

NHS appointments
The NHS Appointments Commission has named two new non-executive members of the National Biological Standards Board (NBSB) for the period August 1 2006 until March 31 2008. The NBSB has statutory functions for the standardisation and control of biologicals used in medicine, and for associated research and development. Michael Beaumont is a chartered accountant and business development consultant, and a Mental Health Act manager at Nottinghamshire healthcare NHS Trust. Professor Karl Nicholson is Professor and Honorary Consultant in Infectious Diseases at the University of Leicester Medical School where his clinical work includes investigating new and emerging diseases.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics